CNCE
Ensign Peak Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-88,341
| Closed | -$516K | – | 1803 |
|
|
2022
Q4 | $516K | Hold |
88,341
| – | – | ﹤0.01% | 1611 |
|
|
2022
Q3 | $592K | Hold |
88,341
| – | – | ﹤0.01% | 1366 |
|
|
2022
Q2 | $372K | Buy |
+88,341
| New | +$372K | ﹤0.01% | 1583 |
|
|
2021
Q1 | – | Sell |
-38,970
| Closed | -$493K | – | 1898 |
|
|
2020
Q4 | $493K | Buy |
+38,970
| New | +$493K | ﹤0.01% | 1608 |
|